CL2017001614A1 - Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados - Google Patents
Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturadosInfo
- Publication number
- CL2017001614A1 CL2017001614A1 CL2017001614A CL2017001614A CL2017001614A1 CL 2017001614 A1 CL2017001614 A1 CL 2017001614A1 CL 2017001614 A CL2017001614 A CL 2017001614A CL 2017001614 A CL2017001614 A CL 2017001614A CL 2017001614 A1 CL2017001614 A1 CL 2017001614A1
- Authority
- CL
- Chile
- Prior art keywords
- composition
- omega
- peso
- compositions
- polyinsaturated
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 12
- 238000000034 method Methods 0.000 title abstract 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 title 1
- 229940012843 omega-3 fatty acid Drugs 0.000 title 1
- 239000006014 omega-3 oil Substances 0.000 title 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 150000004665 fatty acids Chemical class 0.000 abstract 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- 230000001476 alcoholic effect Effects 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 229940033080 omega-6 fatty acid Drugs 0.000 abstract 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings or cooking oils characterised by the production or working-up
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1882—Polyunsaturated fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
<p>LA PRESENTE INVENCIÓN SE REFIERE A PROCESOS PARA AUMENTAR LA ESTABILIDAD DE COMPOSICIONES QUE COMPRENDEN ÁCIDOS GRASOS OMEGA-6 POLIINSATURADOS CONTRA LA OXIDACIÓN. LOS PROCESOS COMPRENDEN LAS SIGUIENTES ETAPAS: (I) PROPORCIONAR UNA COMPOSICIÓN DE PARTIDA QUE COMPRENDE AL MENOS UN COMPONENTE ÁCIDO GRASO OMEGA-6 POLIINSATURADO; (II) PROPORCIONAR UNA COMPOSICIÓN DE LISINA; (III) MEZCLAR SOLUCIONES ACUOSAS, ACUOSO-ALCOHÓLICAS O ALCOHÓLICAS DE COMPOSICIÓN DE PARTIDA Y COMPOSICIÓN DE LISINA, Y SOMETER POSTERIORMENTE LA MEZCLA RESULTANTE A CONDICIONES DE SECADO POR PULVERIZACIÓN, FORMANDO ASÍ UNA COMPOSICIÓN DE PRODUCTO SÓLIDO QUE COMPRENDE AL MENOS UNA SAL DE UN CATIÓN DERIVADO DE LISINA CON UN ANIÓN DERIVADO A PARTIR DE UN ÁCIDO GRASO OMEGA-6 POLIINSATURADO: LA COMPOSICIÓN DEL PRODUCTO QUE PRESENTA UN CONTENIDO DE DISOLVENTE SC SELECCIONADO ENTRE LOS SIGUIENTES: SC ?5% EN PESO, SC ? 3% EN PESO, SC ? 1% EN PESO, SC ? 0.5% EN PESO. LAS COMPOSICIONES OBTENIBLES MEDIANTE TALES PROCESOS DE SECADO POR PULVERIZACIÓN Y EL USO DE TALES COMPOSICIONES PARA LA FABRICACIÓN DE PRODUCTOS ALIMENTICIOS, NUTRICIONALES Y FARMACÉUTICOS ESTÁN COMPRENDIDOS ADEMÁS POR LA PRESENTE INVENCIÓN.</p>
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14199989 | 2014-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2017001614A1 true CL2017001614A1 (es) | 2018-01-12 |
Family
ID=52344991
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2017001614A CL2017001614A1 (es) | 2014-12-23 | 2017-06-19 | Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados |
| CL2020000141A CL2020000141A1 (es) | 2014-12-23 | 2020-01-17 | Composición solida que consisten en al menos 90% en peso de uno o mas sales de cationes derivados de lisina con aniones derivados de uno o mas ácidos grasos omega-3 poliinsaturados. (solicitud divisional 201701614). |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2020000141A CL2020000141A1 (es) | 2014-12-23 | 2020-01-17 | Composición solida que consisten en al menos 90% en peso de uno o mas sales de cationes derivados de lisina con aniones derivados de uno o mas ácidos grasos omega-3 poliinsaturados. (solicitud divisional 201701614). |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US10798962B2 (es) |
| EP (1) | EP3236782B1 (es) |
| JP (1) | JP6861156B2 (es) |
| KR (1) | KR102584130B1 (es) |
| CN (1) | CN107105746B (es) |
| AU (1) | AU2015371376B2 (es) |
| BR (1) | BR112017013319B1 (es) |
| CL (2) | CL2017001614A1 (es) |
| CO (1) | CO2017005847A2 (es) |
| DK (1) | DK3236782T3 (es) |
| ES (1) | ES2781863T3 (es) |
| HU (1) | HUE048494T2 (es) |
| IL (1) | IL252481B (es) |
| MX (1) | MX384154B (es) |
| MY (1) | MY179033A (es) |
| PE (1) | PE20171083A1 (es) |
| PH (1) | PH12017501145A1 (es) |
| PL (1) | PL3236782T3 (es) |
| RU (1) | RU2706202C2 (es) |
| SA (1) | SA517381763B1 (es) |
| SG (1) | SG11201704396XA (es) |
| TW (1) | TWI695682B (es) |
| WO (1) | WO2016102323A1 (es) |
| ZA (1) | ZA201704820B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110087493A (zh) * | 2016-12-13 | 2019-08-02 | 帝斯曼知识产权资产管理有限公司 | Pufa盐制剂(ii) |
| AU2017376402B2 (en) * | 2016-12-13 | 2021-10-28 | Dsm Ip Assets B.V. | PUFA salt formulations (I) |
| KR102628351B1 (ko) * | 2017-08-15 | 2024-01-25 | 에보니크 오퍼레이션즈 게엠베하 | 오메가-3 지방산 아미노산 염의 높은 활성 성분 함량을 갖는 정제 |
| EP3586640A1 (en) | 2018-06-21 | 2020-01-01 | Nuseed Pty Ltd | Dha enriched polyunsaturated fatty acid compositions |
| EP3586642A1 (en) | 2018-06-21 | 2020-01-01 | Nuseed Pty Ltd | Ala enriched polyunsaturated fatty acid compositions |
| EP3586643A1 (en) | 2018-06-21 | 2020-01-01 | Nuseed Pty Ltd | Dha enriched polyunsaturated fatty acid compositions |
| EP3586641A1 (en) | 2018-06-21 | 2020-01-01 | Nuseed Pty Ltd | Dha enriched polyunsaturated fatty acid compositions |
| US20210392935A1 (en) | 2018-11-30 | 2021-12-23 | Evonik Operations Gmbh | Preparation comprising a probiotic strain of the genus bacillus megaterium and a polyunsaturated fatty acid component |
| BR112021010240A2 (pt) | 2018-11-30 | 2021-08-17 | Evonik Operations Gmbh | preparação que compreende uma dispersão de fosfolipídeos e sais de ácidos graxos |
| WO2020109480A1 (en) | 2018-11-30 | 2020-06-04 | Evonik Operations Gmbh | Preparation for use to increase the formation of one or more specialized pro-resolving lipid mediators (spm) |
| EP3965755A1 (en) | 2019-05-06 | 2022-03-16 | Evonik Operations GmbH | Preparation for use in weight management comprising omega-3 fatty acid salts and basic amino acids |
| US12342842B2 (en) | 2019-05-23 | 2025-07-01 | Evonik Operations Gmbh | Preparation for use in enhancing formation of short-chain fatty acids (SCFAs) |
| CN118252869A (zh) * | 2019-08-01 | 2024-06-28 | 赢创运营有限公司 | 包含ω-3脂肪酸盐和来自乳香属物种的胶树脂提取物的制剂 |
| ES3038192T3 (en) | 2019-08-08 | 2025-10-10 | Evonik Operations Gmbh | Method of preparing a solid dosage form and a lubricant |
| EP3804699A1 (en) | 2019-10-10 | 2021-04-14 | Evonik Operations GmbH | Method of preparing a solid dosage form and a binder |
| US20220287345A1 (en) | 2019-08-08 | 2022-09-15 | Evonik Operations Gmbh | Solubility enhancement of poorly soluble actives |
| KR102977459B1 (ko) * | 2019-08-08 | 2026-06-16 | 에보니크 오퍼레이션즈 게엠베하 | 다중불포화 지방산 염의 제조를 위한 다운스트림 공정 |
| ES3038193T3 (en) | 2019-08-08 | 2025-10-10 | Evonik Operations Gmbh | Method of preparing a solid dosage form and a binder |
| EP4097201A4 (en) * | 2020-01-30 | 2024-01-24 | Silicycle Inc. | METHOD FOR PREPARING A SOLID FORM OF BASIC AMINO ACID SALTS OF POLYUNSATURATED FATTY ACIDS |
| AU2021213078A1 (en) * | 2020-01-30 | 2022-09-08 | Silicycle Inc. | Process for manufacturing solid neutral amino acid salts of polyunsaturated fatty acids |
| WO2021197971A1 (en) | 2020-04-01 | 2021-10-07 | Evonik Operations Gmbh | Preparation for use as antioxidant |
| EP4125437A1 (en) | 2020-04-01 | 2023-02-08 | Evonik Operations GmbH | Preparation for use as vasorelaxant |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2945049A (en) | 1959-05-25 | 1960-07-12 | Gen Mills Inc | Salts of basic amino acids and linoleic acid |
| HU199775B (en) * | 1988-03-09 | 1990-03-28 | Nagy Peter Literati | Process for production of formed by fatty acids salts of amin acids and medical compositions containing them |
| IT1264987B1 (it) | 1993-12-14 | 1996-10-17 | Prospa Bv | Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono |
| KR960013387A (ko) * | 1994-10-13 | 1996-05-22 | 오동빈 | Dha과립분말 및 그의 제조방법 |
| CN1463745A (zh) * | 2002-06-14 | 2003-12-31 | 丁强 | 一种全元营养素补充剂 |
| US20140199313A1 (en) * | 2005-03-02 | 2014-07-17 | Metanomics Gmbh | Process for the Production of Fine Chemicals |
| US7867538B2 (en) * | 2005-12-20 | 2011-01-11 | Archer Daniels Midland Company | Processes of improving the quality of oil and products produced therefrom |
| KR20090046773A (ko) * | 2006-06-05 | 2009-05-11 | 오션 뉴트리션 캐나다 리미티드 | 개선된 쉘을 가지는 마이크로캡슐 |
| EP2037746A4 (en) * | 2006-06-29 | 2010-09-22 | Martek Biosciences Corp | GREATEST OIL COMPOSITIONS AND MANUFACTURING METHOD THEREFOR |
| US8975299B2 (en) * | 2007-11-01 | 2015-03-10 | Enzymotec Ltd. | Lipid mixture for infant nutrition |
| EP2366766B8 (en) | 2010-03-09 | 2017-04-19 | Stepan Specialty Products, LLC | Method of treating an edible oil and oil thus obtained |
| US8609138B2 (en) * | 2010-06-30 | 2013-12-17 | Mochida Pharmaceutical Co., Ltd. | ω3 fatty acid compound preparation |
| WO2014011895A2 (en) * | 2012-07-11 | 2014-01-16 | Thetis Pharmaceuticals Llc | High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof |
-
2015
- 2015-12-17 KR KR1020177016894A patent/KR102584130B1/ko active Active
- 2015-12-17 CN CN201580070557.5A patent/CN107105746B/zh active Active
- 2015-12-17 JP JP2017533769A patent/JP6861156B2/ja active Active
- 2015-12-17 ES ES15810737T patent/ES2781863T3/es active Active
- 2015-12-17 DK DK15810737.5T patent/DK3236782T3/da active
- 2015-12-17 US US15/538,825 patent/US10798962B2/en active Active
- 2015-12-17 HU HUE15810737A patent/HUE048494T2/hu unknown
- 2015-12-17 WO PCT/EP2015/080311 patent/WO2016102323A1/en not_active Ceased
- 2015-12-17 RU RU2017125962A patent/RU2706202C2/ru active
- 2015-12-17 PL PL15810737T patent/PL3236782T3/pl unknown
- 2015-12-17 AU AU2015371376A patent/AU2015371376B2/en active Active
- 2015-12-17 MY MYPI2017702241A patent/MY179033A/en unknown
- 2015-12-17 EP EP15810737.5A patent/EP3236782B1/en active Active
- 2015-12-17 PE PE2017001087A patent/PE20171083A1/es unknown
- 2015-12-17 BR BR112017013319-9A patent/BR112017013319B1/pt active IP Right Grant
- 2015-12-17 MX MX2017007846A patent/MX384154B/es unknown
- 2015-12-17 SG SG11201704396XA patent/SG11201704396XA/en unknown
- 2015-12-18 TW TW104142798A patent/TWI695682B/zh not_active IP Right Cessation
-
2017
- 2017-05-24 IL IL252481A patent/IL252481B/en unknown
- 2017-06-14 CO CONC2017/0005847A patent/CO2017005847A2/es unknown
- 2017-06-18 SA SA517381763A patent/SA517381763B1/ar unknown
- 2017-06-19 PH PH12017501145A patent/PH12017501145A1/en unknown
- 2017-06-19 CL CL2017001614A patent/CL2017001614A1/es unknown
- 2017-07-17 ZA ZA2017/04820A patent/ZA201704820B/en unknown
-
2020
- 2020-01-17 CL CL2020000141A patent/CL2020000141A1/es unknown
- 2020-08-18 US US16/947,809 patent/US11805798B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017005847A2 (es) | Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados | |
| CL2017001613A1 (es) | Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-6 poliinsaturados | |
| CL2020002269A1 (es) | Anticuerpo que se une a redil33; polinucleótido; vector; célula hospedadora; método para producir el anticuerpo; composición farmacéutica; producto de combinación; uso del anticuerpo para tratar una afección inflamatoria (divisional de la solicitud no. 201702433) | |
| NZ747847A (en) | Lipid compositions | |
| AR106204A1 (es) | Método para fabricar una confitura congelada con revestimiento bajo en sfa y producto obtenido | |
| BR112018074009A2 (pt) | método para preparar uma composição compreendendo sais de ácidos graxos ômega-3 | |
| MX2016011290A (es) | Composiciones de ester de colina de acido lipoico y metodos de uso. | |
| WO2015171460A3 (en) | Formulations of cyclophosphamide liquid concentrate | |
| CL2017000475A1 (es) | Composición para formulación cosmética que consiste en una mezcla de hasta 3 componentes seleccionados de manteca de murumuru, manteca de ucuuba, aceite de nuez de brasil, aceite de maracuyá, manteca de copoazú, aceite de acai y aceite de andiroba y/o ésteres de los mismos; producto cosmético. | |
| AR105144A1 (es) | Composiciones nutricionales y métodos para promover el desarrollo cognitivo | |
| WO2015011724A3 (en) | A novel omega -3 fatty acid composition with a plant extract | |
| CL2016001375A1 (es) | Composición, que comprende agente bioactivo (inmunógeno) dispersado en gotitas de aceite, polímero de recubrimiento entérico, un polímero mucoadhesivo, su método de preparación y uso para la administración oral de un agente bioactivo. | |
| BR112014024523A2 (pt) | sistema de gordura de panificação | |
| WO2016137825A8 (en) | Millicapsule formulations comprising polyunsaturated free fatty acids | |
| BR112016028561A8 (pt) | composição e forma de dosagem compreendendo um óleo marinho que compreende ácidos graxos, e, uso das mesmas | |
| PE20170250A1 (es) | Composiciones estructuradas de grasa vegetal, proceso para obtener dicha composicion estructurada de grasas, uso de la composicion estructurada de grasas en la preparacion de una composicion cosmetica, composicion cosmetica y producto que comprende dicha composicion estructurada de grasas | |
| MX2016012440A (es) | Composicion de carbohidrato y proceso para la elaboracion de una composicion de carbohidrato. | |
| EA201692398A1 (ru) | Гомогенная композиция для перорального введения, содержащая омега-3 полиненасыщенные жирные кислоты и ресвератрол | |
| CL2018000753A1 (es) | Gel hidrófobo basado en vitamina e libre de productos de silicona para aplicación tópica | |
| CL2017002828A1 (es) | Composición para tratamiento de estrés oxidativo y enfermedad cardiovascular | |
| MX348893B (es) | Composicion blanqueadora. | |
| MX2015002077A (es) | Procedimiento para la obtencion de un colorante alimentario liquido con base en rizomas de la curcuma longa l. | |
| NZ732380B2 (en) | Process for increasing the stability of a composition comprising polyunsaturated omega-6 fatty acids | |
| AR095832A1 (es) | Composición farmacéutica oral útil para el trastorno del déficit de atención e hiperactividad, suplemento nutricional y alimento que la comprenden y proceso para preparar la composición | |
| JP2017039666A5 (es) |